Drug intelligence / Profile preview

Yinling Qushi Granules

Development stage: Unknown
Administration: Oral

Overview

This product likely belongs to the category of traditional Chinese medicine used for clearing dampness and heat. However, specific details about its composition, mechanism of action, or primary indications are not available in the search results.

Targets

AGTR1 (Angiotensin II Type-1 receptor)HSD11B1 (11-beta-hydroxysteroid dehydrogenase type 1)

Beyond the preview

Go deeper on Yinling Qushi Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinling Qushi Granules.

Explore the full profile